Gene · 55872
Papers1,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Roles of TOPK in Tumorigenesis and Development: Structure, Mechanisms, Pathways, and Therapeutic Implications. | Int J Biol Sci | 2026 | 41362722 | PubTator, text mining | PubMed |
| Exploring the Interconnections Between Mitochondrial Dysfunction and Polycystic Ovary Syndrome: A Comprehensive Integrated Analysis. | Biochem Genet | 2026 | 40259200 | PubTator, text mining | PubMed |
| Convolutional neural networks and mixture of experts for intrusion detection in 5G networks and beyond. | Front Artif Intell | 2025 | 41561190 | PubTator, text mining | PubMed |
| Phosphorylation of shiftless is important for inhibiting the programmed -1 ribosomal frameshift. | Sci Adv | 2025 | 41417896 | PubTator, text mining | PubMed |
| Enhanced model inversion via frequency disentanglement and latent space optimization. | Sci Rep | 2025 | 41318698 | PubTator, text mining | PubMed |
| Enhancing healthcare consensus mechanism - A reputation integrated variant of PBFT (BR-PBFT). | PLoS One | 2025 | 41218054 | PubTator, text mining | PubMed |
| Letter to the editor comments on 'PBK as a Novel Biomarker with Excellent Diagnostic and Prognostic Value in HCC Associated with Immune Infiltration and Methylation'. | J Mol Histol | 2025 | 41186758 | PubTator, text mining | PubMed |
| Identification of Prognostic Gene Signatures for Survival of Patients With Phaeochromocytoma, Paraganglioma, and Other Tumor Types. | Cancer Diagn Progn | 2025 | 41179328 | PubTator, text mining | PubMed |
| Dual Weakly Supervised Anomaly Detection and Unsupervised Segmentation for Real-Time Railway Perimeter Intrusion Monitoring. | Sensors (Basel) | 2025 | 41157396 | PubTator, text mining | PubMed |
| [PDZ-binding kinase as a prognostic biomarker for pancreatic cancer: a pan-cancer analysis and validation in pancreatic adenocarcinoma cells]. | Nan Fang Yi Ke Da Xue Xue Bao | 2025 | 41139451 | PubTator, text mining | PubMed |
| MolGraph-xLSTM as a graph-based dual-level xLSTM framework for enhanced molecular representation and interpretability. | Commun Chem | 2025 | 41023138 | PubTator, text mining | PubMed |
| An enhanced approach for automatic annotation of error codes based on Seq2edit. | PeerJ Comput Sci | 2025 | 40989426 | PubTator, text mining | PubMed |
| PBK/TOPK mediates Ikaros, Aiolos and CTCF displacement from mitotic chromosomes and alters chromatin accessibility at selected C2H2-zinc finger protein binding sites. | Nat Commun | 2025 | 40987773 | PubTator, text mining | PubMed |
| The SRC-TOPK positive feedback loop promotes RB1 phosphorylation and drives the development of lung squamous cell carcinoma. | Acta Biochim Biophys Sin (Shanghai) | 2025 | 40908875 | PubTator, text mining | PubMed |
| Targeting PBK in the fibroblast-to-myofibroblast transition: A novel therapeutic strategy for IPF. | Biochem Pharmacol | 2025 | 40885317 | PubTator, text mining | PubMed |
| Mechanistic Insights and Clinical Implications of ELK1 in Solid Tumors: A Narrative Review. | Cells | 2025 | 40862737 | PubTator, text mining | PubMed |
| PF-AGCN: an adaptive graph convolutional network for protein-protein interaction-based function prediction. | Bioinformatics | 2025 | 40857391 | PubTator, text mining | PubMed |
| Correction: CLDN6 triggers NRF2-mediated ferroptosis through recruiting DLG1/PBK complex in breast cancer. | Cell Death Dis | 2025 | 40841418 | PubTator, text mining | PubMed |
| LABind: identifying protein binding ligand-aware sites via learning interactions between ligand and protein. | Nat Commun | 2025 | 40830361 | PubTator, text mining | PubMed |
| Sparse autoencoders uncover biologically interpretable features in protein language model representations. | Proc Natl Acad Sci U S A | 2025 | 40828027 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55872/papers?page=3